Biora Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Biora Therapeutics

26/03/2024 21:01

* Biora Therapeutics Inc  BIOR.OQ  reported a quarterly
adjusted
loss of 62 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of $-1.64.  The mean expectation of two analysts
for the quarter was for a loss of 59 cents per share. Wall
Street expected results to range from -74 cents to -45 cents per
share.
    * Reported revenue was zero​; analysts expected $5.00
hundred. 
    * Biora Therapeutics Inc's reported EPS for the quarter was
a loss
of 62 cents​.
    * The company reported a quarterly loss of $15.41 million.
    * Biora Therapeutics Inc shares had fallen by 9.6% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Biora
Therapeutics Inc is $27.80 

This summary was machine generated from LSEG data March 26 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.59          -0.62          Missed
 Sep. 30 2023      -0.92          -4.89          Missed
 Jun. 30 2023      -1.60          -1.47          Beat
                                  -1.59